Columbus McKinnon Corporation — Form 10-Q Summary
Business context and reporting period
Columbus McKinnon designs, manufactures and markets material-handling products and services, including hoists, cranes, rigging tools and actuators. Products are sold globally, primarily through third-party distributors. The filing covers the three and nine months ended December 31, 2012, the third quarter and first nine months of fiscal 2013. Approximately 44% of nine-month sales were generated outside the United States.
Key financial metrics
| Metric | Three months ended Dec. 31, 2012 | Three months ended Dec. 31, 2011 | Nine months ended Dec. 31, 2012 | Nine months ended Dec. 31, 2011 |
|---|---|---|---|---|
| Net sales | $153.2 million | $142.8 million | $452.7 million | $432.4 million |
| Gross profit | $43.8 million | $38.6 million | $130.0 million | $113.5 million |
| Gross margin | 28.6% | 27.0% | 28.7% | 26.2% |
| Operating income | $14.2 million | $12.0 million | $39.9 million | $31.5 million |
| Operating margin | 9.3% | 8.4% | 8.8% | 7.3% |
| Net income | $9.6 million | $8.5 million | $26.3 million | $18.0 million |
| Diluted EPS | $0.49 | $0.44 | $1.34 | $0.92 |
| Operating cash flow | Not separately provided | Not separately provided | $26.3 million | $13.5 million |
Third-quarter sales increased 7.3%, while nine-month sales increased 4.7%. Gross profit increased 13.5% in the quarter and 14.6% year to date. Net income increased 12.5% in the quarter and 46.2% year to date. The filing does not provide a separately reported EBITDA measure.
At December 31, 2012, cash and cash equivalents were $111.9 million, compared with $89.5 million at March 31, 2012. Current assets were $301.3 million and current liabilities were $83.0 million, implying a current ratio of approximately 3.6x. Total debt, including current debt, senior debt and subordinated debt, was approximately $152.3 million. The company had no revolver borrowings and $88.5 million of unused revolver capacity after outstanding letters of credit. Marketable securities of $23.7 million were held for insurance claims and were not available for general working capital.
Material changes versus the prior comparable period
- Sales growth reflected $6.5 million of volume and mix benefits, $4.9 million from two additional shipping days and $3.8 million from price increases in the quarter. Foreign currency translation reduced quarterly sales by $2.0 million.
- Year-to-date sales benefited from $25.2 million of volume and mix, $12.9 million of price increases and one additional shipping day, offset by $16.3 million of unfavorable currency translation.
- Gross margin improved by 160 basis points in the quarter and 250 basis points year to date. Pricing, volume, productivity and lower product-liability expense more than offset material inflation and unfavorable productivity in the quarter.
- Selling expense increased with sales and investments in developing markets, while general and administrative expense increased due to pension and benefit costs, ERP implementation, Asia-Pacific growth investments and inflation.
- No restructuring costs were recorded in fiscal 2013. The prior-year periods included a $1.5 million net gain from the sale of a closed manufacturing facility and $0.4 million of restructuring costs year to date.
- Operating cash flow nearly doubled year to date, primarily because of higher earnings and reductions in accounts receivable and inventory. Capital expenditures declined to $7.1 million from $10.5 million.
- The company completed a new $100 million revolving credit facility in October 2012, replacing the prior $85 million facility and extending the maturity to October 31, 2017.
Guidance, outlook, commentary, risks and unusual items
- Management expects fiscal 2013 capital expenditures of approximately $12 million to $15 million, compared with $13.8 million in fiscal 2012.
- Management estimates a fiscal 2013 effective tax rate of approximately 13% to 17%, subject to the geographic mix of taxable income and possible changes in the deferred tax asset valuation allowance.
- Management believes cash, operating cash flow and revolver capacity will fund operations and budgeted capital expenditures for at least the next twelve months, assuming successful execution of the business plan and effective working-capital management.
- Key operating sensitivities include global industrial demand, Eurozone conditions, steel and energy costs, foreign exchange rates, customer and supplier conditions, competition, acquisitions, restructuring and market acceptance of products.
- The company purchases approximately $30 million to $40 million of steel annually and generally seeks to offset cost increases through price increases or surcharges. Some steel costs increased during the period.
- Goodwill totaled $106.1 million. Management’s qualitative assessment did not identify a current impairment risk, but declines in forecast revenue, margins or cash flows, or higher discount rates, could result in future impairment charges.
- Asbestos-related liability was estimated at $10.7 million, within an actuarial range of $8 million to $13 million; approximately $2 million of related settlement costs and legal fees are expected over the next twelve months. Product-related liability was estimated at $6.4 million.
- The company reported no material legal proceedings in Part II, but asbestos and product-liability matters remain material contingencies. Total asbestos-related and product-related liabilities declined to approximately $17.1 million from $20.5 million at March 31, 2012.
- The company’s $150 million 7 7/8% senior subordinated notes mature in 2019 and include restrictions on indebtedness, asset sales, dividends and other payments. The company was in compliance with its credit covenants at December 31, 2012.
- There was no material change in reported market risks or risk factors from the prior Form 10-K. Management concluded that disclosure controls and procedures were effective.
Important facts for investors to verify
- Whether improved gross margins can be sustained as steel, labor, pension, health-care and energy costs change.
- The durability of demand in North America, Europe and emerging markets, particularly given the recent decline in Eurozone industrial-capacity utilization.
- Progress and spending related to the global ERP implementation and other growth investments.
- Actual fiscal 2013 capital expenditures and effective tax rate relative to management’s stated ranges.
- Future asbestos and product-liability claims, settlement costs and the adequacy of recorded reserves.
- Goodwill impairment indicators and the sensitivity of reporting-unit valuations to revenue, margin, terminal-growth and discount-rate assumptions.
- Availability under the revolver after letters of credit, compliance with leverage and fixed-charge covenants, and the 2019 subordinated-note maturity.
- The extent to which foreign-currency translation, pricing actions and acquisitions or divestitures affect reported growth.